Skip to main content
main-content

Über dieses Buch

The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal funding control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime.
The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research.

Inhaltsverzeichnis

Frontmatter

Chapter 1. Stem Cell Tourism Phenomenon in China: An Introduction

Biotechnology raises many controversies, particularly in the area of HESC research.
Li Jiang

Chapter 2. The Legal Framework of Stem Cell Science and Medicine in China: An Overview

Travel to another country for stem cell treatment, “stem cell tourism”, has boomed in recent years. China became one of the best destinations for stem cell therapy. According to some studies, the main incentive and motivation of stem cell tourism is a belief in the potential efficacy of the provided treatment and a faint help that the treatment might help.
Li Jiang

Chapter 3. The Moral Dilemma of Stem Cell Science and Medicine

The problematic issues that the source and derivation of HESC leads to the immoral research were addressed. Although this research is about how to tackle with the HESC regulation in China, it will inevitably encounter moral issues when examining problems related to HESC. In most circumstances, morality may not coincide with the law. But, moral obstacles are significant issues to inventions related to HESC research.
Li Jiang

Chapter 4. Stem Cells, Patents and Regulation in China: Inadequacy

Despite the bright future of HESC research in conquering incurable diseases, its development faces many legal and ethical challenges. The complexity of HESC research creates most unusual and fraught situations for regulators in China.
Li Jiang

Chapter 5. Stem Cells, Patents and Policy in the US: Inefficiency

The question of the morality of HESC related invention and the inadequate HESC regulation in China has been widely addressed in previous chapter. This chapter will address how effective the US deals with the patentability and morality disputes on HESC.
Li Jiang

Chapter 6. Stem Cells, Patents and Morality in the EU: Inconsistency

In the EUROPE, morality is deeply rooted in regulation. The EUROPE regulation of HESC research related to moral concerns has adopted an approach which is to infuse patent examination with a moral assessment. Although many scholars and legal practitioners have agreed that patent law is not the proper vehicle for enforcing morality and that patent examiners are not experts on moral issues, the patent-granting agencies in the EUROPE are responsible for interpreting moral provisions. At the EUROPE level, the European Patent Convention contains a morality clause to exclude patenting immoral inventions, whereas the morality standard developed in case laws established two inconsistent standards (“abhorrence” and “unacceptability”).
Li Jiang

Chapter 7. Proposal for Controlling Stem Cell Science and Medicine in China: Internationalism

This book has addressed the research question of what is a better way to regulate HESC research in China? This study has been motivated by the recent developments in the HESC technology.
Li Jiang

Backmatter

Weitere Informationen

Premium Partner

BranchenIndex Online

Die B2B-Firmensuche für Industrie und Wirtschaft: Kostenfrei in Firmenprofilen nach Lieferanten, Herstellern, Dienstleistern und Händlern recherchieren.

Whitepaper

- ANZEIGE -

Voraussetzungen für die wirtschaftliche additive Fertigung

Viele Unternehmen stellen die technische Umsetzbarkeit oder die Wirtschaftlichkeit additiv gefertigter Produkte in Frage und zögern bei der Anwendung. Mit einer neuen Denkweise führt die additive Fertigung jedoch zu höherer Wirtschaftlichkeit und Vorteilen im Wettbewerb, wie Kegelmann Technik in diesem Beitrag beschreibt.
Jetzt gratis downloaden!

Bildnachweise